Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
-0.12 (-0.48%)
After-hours: Mar 9, 2026, 6:20 PM EDT
Arcutis Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -16.14 | -140.04 | -262.14 | -311.46 | -206.36 | |
| Depreciation & Amortization | 4.67 | 1.96 | 0.75 | 0.93 | 0.45 | |
| Asset Writedown & Restructuring Costs | - | - | - | 29.63 | - | |
| Loss (Gain) From Sale of Investments | -2.09 | -6.9 | -6.99 | -2.25 | 3.45 | |
| Stock-Based Compensation | 40.36 | 41.73 | 38.81 | 32.68 | 23.89 | |
| Other Operating Activities | 2.41 | 6.17 | 6.01 | 2.93 | 0.31 | |
| Change in Accounts Receivable | -73.16 | -47.26 | -17.35 | -8.46 | - | |
| Change in Inventory | -7.33 | -0.4 | -5.62 | -7.51 | - | |
| Change in Accounts Payable | -1.69 | 2.23 | 3.15 | 1.57 | 0.25 | |
| Change in Other Net Operating Assets | 47.36 | 30.35 | -3.68 | 4.23 | 3.38 | |
| Operating Cash Flow | -5.63 | -112.16 | -247.06 | -257.72 | -174.63 | |
| Capital Expenditures | -0.69 | -0.14 | -0.43 | -0.33 | -1 | |
| Sale (Purchase) of Intangibles | -10 | -5 | - | -22.95 | - | |
| Investment in Securities | -19.57 | 33.96 | 180.66 | -63.92 | -74.96 | |
| Investing Cash Flow | -30.25 | 28.82 | 180.23 | -87.2 | -75.95 | |
| Long-Term Debt Issued | - | - | - | 125 | 73.99 | |
| Long-Term Debt Repaid | - | -100 | - | - | - | |
| Net Debt Issued (Repaid) | - | -100 | - | 125 | 73.99 | |
| Issuance of Common Stock | 6.97 | 166.2 | 101.32 | 178.99 | 209.6 | |
| Other Financing Activities | - | - | - | -2.19 | -1.64 | |
| Financing Cash Flow | 6.97 | 66.2 | 101.32 | 301.8 | 281.95 | |
| Foreign Exchange Rate Adjustments | 0.17 | -0.24 | -0.05 | - | - | |
| Net Cash Flow | -28.74 | -17.37 | 34.45 | -43.12 | 31.37 | |
| Free Cash Flow | -6.31 | -112.3 | -247.49 | -258.05 | -175.62 | |
| Free Cash Flow Margin | -1.68% | -57.14% | -415.20% | -7000.76% | - | |
| Free Cash Flow Per Share | -0.05 | -0.93 | -3.57 | -4.69 | -3.56 | |
| Cash Interest Paid | 10.33 | 22.21 | 25.45 | 12.64 | 0.14 | |
| Levered Free Cash Flow | -15.41 | -72.9 | -152.09 | -195.81 | -102.77 | |
| Unlevered Free Cash Flow | -7.86 | -55.92 | -133.52 | -186.03 | -102.77 | |
| Change in Working Capital | -34.83 | -15.08 | -23.5 | -10.18 | 3.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.